Seventy-eight percent of the stock screens AAII tracks posted gains during 2025, with an average gain of 14.7%.

In the UK alone, nearly 6,000 deaths each year are attributed to suicide whilst the number of attempts is significantly ...

A reader objects to a defense of disparate-impact theory.

If you’re going online to buy some last-minute gifts this holiday season, there’s a chance the price you pay will be influenced by what’s known as “surveillance pricing.” Some retailers are using ...

A new study reveals an alarming bias present in four leading AI cancer screening tools, related to race, gender, and age.

With one in eight women expected to be diagnosed with breast cancer in their lifetime, CCS believes that screening programs should start at age 40. Given that 13% of breast cancer cases are diagnosed ...

The FDA has granted 510(k) clearance to a Bay Area medical technology firm for its proprietary delirium monitoring solution, ...

A study published in The BMJ linked skipping first and subsequent mammograms to a higher chance of dying from breast cancer. Experts explain the findings.

Long-term results from a European study showed that prostate cancer mortality was 13% lower in the PSA screening group versus the control group. Compared with the trial update at 16 years, the number ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...

UNIONTOWN, Ohio — Securitas has formalized a strategic partnership with Rohde & Schwarz, a provider of artificial intelligence-based millimeter wave screening technology. Described as a long-term ...